Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas
Open Access
- 8 January 2007
- Vol. 109 (2) , 256-264
- https://doi.org/10.1002/cncr.22394
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Hodgkin Disease/Lymphoma Clinical Practice GuidelinesJournal of the National Comprehensive Cancer Network, 2006
- Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trialBlood, 2004
- Current treatment strategies in early stage hodgkin’s diseaseCurrent Treatment Options in Oncology, 2003
- Treatment of patients with advanced or bulky Hodgkin disease with a 12‐week doxorubicin, bleomycin, vinblastine, and dacarbazine‐like chemotherapy regimen followed by extended‐field, full‐dose radiotherapyCancer, 2002
- Comparison of prognostic models in patients with advanced Hodgkin diseaseCancer, 2001
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.Journal of Clinical Oncology, 1996
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.Journal of Clinical Oncology, 1990